ARCHIVES

ASCO Annual Meeting Attendance Tops 25,000, Continuing Fast Growth.

This article is from The Cancer Letter archive.

Vol. 27 No. 20 | May 18, 2001

Download PDF Visit The Full Archive

Related Articles

NIH, FDA to tighten, review consulting rules as Congressional inquiry continues.

May 21, 2004

Pfizer Begins Phase III Trial Of Sunitinib In NSCLC

September 28, 2007

DCE Recompetition Of Human Tissue Procurement Approved

November 23, 1990

CCOP Success Acknowledged, Recompetition Plans Being Made; Cancer Control May Be Added To RFA

April 11, 1986

FDA Issues Final Rules On Patient Access To Investigational Drugs

September 11, 2009

Called “Unscrupulous” in Abramson Lawsuit, Thompson Calls Abramson A Rich Man Scorned

March 23, 2012